<DOC>
	<DOCNO>NCT01368978</DOCNO>
	<brief_summary>This study prospective , single-center , open label , randomize ; two-arms cross study . This test protocol InsuPatch device , whose purpose improve insulin delivery blood insulin infuse use insulin-infusion pump control heating area surround point infusion .</brief_summary>
	<brief_title>Pediatric Diabetics Type 1 Using InsuPatch</brief_title>
	<detailed_description>Twenty ( 20 ) type 1 child Type 1 Diabetics Mellitus ( TIDM ) meeting inclusion/exclusion criterion outline provide write Informed Consent enrol study . The study consist outpatient enrollment visit two admission ( One clamp InsuPatch one clamp without InsuPatch ) . Each Subject thus serve his/her control .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Age 1217 ( inclusive ) 2 . Clinical diagnosis T1DM least one year 's duration 3 . On CSII therapy least three month 4 . Hemoglobin A1c ( HBA1C ) value 10 % 6.5 % 5 . Minimum weight requirement least 37.9 Kg . 6 . Ability comprehend write spoken English 7 . Body Mass Index zscore 90 % 1 . Celiac disease , gastroparesis , gastrointestinal disorder associate alerted carbohydrate absorption intestinal motility . 2 . Medication besides insulin know alter blood glucose , gastric motility , intestinal carbohydrate absorption 3 . Female subject reproductive potential pregnant breast feed 4 . Inability comprehend write spoken English 5 . Any condition , judgment investigator , would interfere subject 's parent ' ability provide inform consent investigator 's ability perform study . 6 . Hematocrit 35 serum potassium 3.4 ( confirm two sample )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>TIDM</keyword>
</DOC>